ArticleThe European respiratory journal2017
Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use.
Jeffrey Hafkin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it